Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Understanding the value of credit card points versus cash back will help you make informed financial decisions. Discover which option gives you better returns.
26,454 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Netflix has stumbled this year, leaving many investors wondering what comes next. This guide explains the drop, what ...
Bitcoin could mount a major rally as a liquidity wave from Washington enters the system. A market note outlines two p...
Nebius stock fell today after the company announced debt issuance to fund its infrastructure push and key AI partners...
A practical guide to Warner Music’s 2026 outlook for investors. Explore growth drivers, margins, and the risks that c...
What could Nu Holdings look like a decade from now? This article breaks down growth catalysts, potential paths, and p...
As the fourth quarter wrapped up, foreclosure auctions surged last, signaling rising distress in several markets. Thi...
Federal Reserve Governor Christopher Waller signaled that he does not support additional rate hikes for now and expec...
Paradigm just closed a $1.2B fund, signaling a bold move at the intersection of crypto and AI. This Morning Minute ex...
Clorox has stacked a long streak of dividend increases, but reaching 50 years could hinge on a crucial strategic shif...
GRNY beats COWZ by 11 points this year, signaling a tilt toward AI, electrification, and energy themes. Oil prices an...
Explore how Invitation Homes navigated Q4 2025, the drivers behind its earnings, and what savvy investors should watc...